Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Tuesday, 2026-03-03. Here’s what investors need to know before the announcement.
Analysts estimate that Rigel Pharmaceuticals will report an earnings per share (EPS) of $1.25.
Anticipation surrounds Rigel Pharmaceuticals’s announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Past Earnings Performance
During the last quarter, the company reported an EPS beat by $0.61, leading to a 33.37% increase in the share price on the subsequent day.
Here’s a look at Rigel Pharmaceuticals’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.85 | 1.63 | 0.09 | 0.55 |
| EPS Actual | 1.46 | 3.28 | 0.63 | 0.80 |
| Price Change % | 33.37 | 22.98 | 1.15 | -8.11 |
Market Performance of Rigel Pharmaceuticals’s Stock
Shares of Rigel Pharmaceuticals were trading at $34.74 as of February 27. Over the last 52-week period, shares are up 56.7%. Given that these …